MREO - Financial Reports List - Mereo BioPharma Group plc - IntrinsicAlpha

Mereo BioPharma Group plc MREO

Healthcare - Biotechnology - NASDAQ - GB

$ 2.46

1.3 %

$ 382 M

Market Cap

-7.77

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-16.53%	-168.32%
Annual Report	FY	10-K	2024-12-31	0.00%	-46.79%	-66.68%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-128.68%	-52.02%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	9.90%	18.65%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-62.30%	-99.82%
Quarterly Report	Q4	8-K	2023-12-31	-56.60%	65.76%	77.72%
Annual Report	FY	10-K	2023-12-31	563.57%	13.83%	34.78%
Quarterly Report	Q3	8-K	2023-09-30	-20.97%	29.81%	51.51%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	45.23%	44.24%
Quarterly Report	Q1	8-K	2023-03-31	670.78%	56.17%	65.41%

1